About MindBio Therapeutics
MindBio Therapeutics is a company based in Melbourne (Australia) founded in 2021 by Justin Hanka. MindBio Therapeutics offers products and services including MB22001. MindBio Therapeutics operates in a competitive market with competitors including Celerion, Ask Gene Pharma, Altasciences, iCardiac Technologies and Avance Clinical, among others.
- Headquarter Melbourne, Australia
- Founders Justin Hanka
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website mindbiotherapeutics.com
- Social LinkedIn X
- Legal Name Mindbio Therapeutics Corp.
- Net Profit-$1.85 M (USD)-579.3as on Jun 30, 2025
- EBITDA-$1.27 M (USD)-185.84as on Jun 30, 2025
- Latest Funding Round$987.91K (USD), Post-IPO
Apr 2026
Products & Services of MindBio Therapeutics
MindBio Therapeutics offers a comprehensive portfolio of products and services, including MB22001.
Microdose psychedelic treatment for major depressive disorder.
Funding Insights of MindBio Therapeutics
- Total Rounds 6
- Last Round Post-IPO — $987,908
All 6 funding rounds of MindBio Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | $987,908 | Post-IPO | – | – | – |
| May 2025 | $66,573 | Post-IPO | – | – | – |
| Apr 2025 | $1.39M | Post-IPO | – | – | – |
| Apr 2025 | $111,684 | Post-IPO | – | – | – |
| Mar 2025 | $490,364 | Post-IPO | – | – | – |
| Dec 2024 | – | Post-IPO | – | – | – |
People of MindBio Therapeutics
1 people are tracked at MindBio Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Justin Hanka | Co-Founder | Leadership |
Complete people profiles for MindBio Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of MindBio Therapeutics
MindBio Therapeutics is a publicly listed company on the CSE with ticker symbol MBIO in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 May 2023
- Listed onCSE: MBIO
- Listed entityMindbio Therapeutics Corp.
- Exchange sectorHealth technology
- ISINCA60256C2076
- Share price0.13 CAD (-3.7% on the day) · 2026-10-08
- Market capitalisation946,798.00 CAD
- EPS (diluted, trailing year)-4.12 CAD
- Volume (last session)1,500
Financials of MindBio Therapeutics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | – | -2.5M CAD | -1.7M CAD |
| 2024 | – | -372,470 CAD | -609,700 CAD |
| 2023 | – | -3.9M CAD | -3.0M CAD |
| 2022 | – | -6.9M CAD | -6.6M CAD |
Detailed financial statements for MindBio Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of MindBio Therapeutics
4 dated milestones of MindBio Therapeutics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded MindBio Therapeutics is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
- Funding Latest funding round, Post-IPO, of $988K.
Competitors of MindBio Therapeutics
MindBio Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celerion, Ask Gene Pharma, Altasciences, iCardiac Technologies and Avance Clinical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celerion.com | 2010 | Lincoln, United States | – | 940 | Early clinical research services are provided for drug development. | |
| ask-gene.com | 2012 | Camarillo, United States | $20M | 24 | Biosimilars and biosuperiors are developed and commercialized in biotechnology. | |
| altasciences.com | 2015 | Laval, Canada | – | 249 | Early phase clinical research services are provided in North America. | |
| icardiac.com | 2006 | Rochester, United States | $4M | – | Cardiac safety testing and respiratory laboratory services are provided. | |
| avancecro.com | 2018 | Thebarton, Australia | – | – | Clinical development services are provided to pharmaceutical clients worldwide. | |
| spauldingclinical.com | 2007 | West Bend, United States | $1.71M | – | CRO services for Phase I Clinical Trials, and Core ECG lab services for trials from Phase I to IV | |
| awaknlifesciences.com | 2020 | Portishead, United Kingdom | – | 49 | CRO focused on early stage clinical trial research | |
| openorphan.com | 2017 | London, United Kingdom | – | 218 | Provider of testing vaccines & antivirals and CRO pharmaceutical services | |
| clerkenwellhealth.com | 2020 | London, United Kingdom | $2.33M | – | CRO focused on conducting early stage clinical development of psychedelic medicines |
Detailed competitors of MindBio Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MindBio Therapeutics
Websites that share an audience with MindBio Therapeutics (mindbiotherapeutics.com).
Websites whose visitors overlap most with MindBio Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
thelimbic.com | thelimbic.com | 100% | – | #798,757 | – |
Latest news on Mindbio Therapeutics
Complete news archive for MindBio Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MindBio Therapeutics
10 companies that operate in the same segment as MindBio Therapeutics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MindBio Therapeutics
MindBio Therapeutics was founded in 2021 and raised its 1st funding round 3 years after it was founded.
MindBio Therapeutics is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
MindBio Therapeutics was established in 2021 and is based in Melbourne, Australia. Clinical trial services at phase I and II levels are provided, with a focus on mental health diseases within the biotechnology sector. Operations center on developing and testing treatments through structured trial protocols. The company is led by co-founder Justin Hanka, supporting research advancements in psychiatric conditions.
MindBio Therapeutics's top competitors include Celerion, Ask Gene Pharma and Altasciences.
MindBio Therapeutics offers MB22001.
Yes, MindBio Therapeutics is publicly traded on CSE under the ticker symbol MBIO.